| ［1］ |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识（2016）［J］. 中华皮肤科杂志, 2017,50（3）:156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2017.03.002.
|
| ［2］ |
Chen YE, Fischbach MA, Belkaid Y. Skin microbiota⁃host interactions［J］. Nature, 2018,553（7689）:427⁃436. doi: 10.1038/nature25177.
|
| ［3］ |
闫慧敏, 赵惠娟, 姜薇. 高通量测序分析红斑期酒渣鼻患者与健康人面部皮肤微生物的分布差异［J］. 中国皮肤性病学杂志, 2016,30（10）:991⁃994,997. doi: 10.13735/j.cjdv.1001⁃7089. 201602060.
|
| ［4］ |
Zaidi AK, Spaunhurst K, Sprockett D, et al. Characterization of the facial microbiome in twins discordant for rosacea［J］. Exp Dermatol, 2018,27（3）:295⁃298. doi: 10.1111/exd.13491.
|
| ［5］ |
Rainer BM, Thompson KG, Antonescu C, et al. Characterization and analysis of the skin microbiota in rosacea: a case⁃control study［J］. Am J Clin Dermatol, 2020,21（1）:139⁃147. doi: 10. 1007/s40257⁃019⁃00471⁃5.
|
| ［6］ |
Woo YR, Lee SH, Cho SH, et al. Characterization and analysis of the skin microbiota in rosacea: impact of systemic antibiotics［J］. J Clin Med, 2020,9（1）:185. doi: 10.3390/jcm9010185.
|
| ［7］ |
Chang YS, Huang YC. Role of Demodex mite infestation in rosacea: a systematic review and meta⁃analysis［J］. J Am Acad Dermatol, 2017,77（3）:441⁃447.e6. doi: 10.1016/j.jaad.2017.03. 040.
|
| ［8］ |
Forton F, De Maertelaer V. Rosacea and demodicosis: little⁃known diagnostic signs and symptoms［J］. Acta Derm Venereol, 2019,99（1）:47⁃52. doi: 10.2340/00015555⁃3041.
|
| ［9］ |
Sahni DR, Feldman SR, Taylor SL. Ivermectin 1% （CD5024） for the treatment of rosacea［J］. Expert Opin Pharmacother, 2018,19（5）:511⁃516. doi: 10.1080/14656566.2018.1447562.
|
| ［10］ |
Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes［J］. J Invest Dermatol, 2011,131（3）:688⁃697. doi: 10.1038/jid.2010.351.
|
| ［11］ |
Margalit A, Kowalczyk MJ, Żaba R, et al. The role of altered cutaneous immune responses in the induction and persistence of rosacea［J］. J Dermatol Sci, 2016,82（1）:3⁃8. doi: 10.1016/j.jdermsci.2015.12.006.
|
| ［12］ |
Forton FM. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link［J］. J Eur Acad Dermatol Venereol, 2012,26（1）:19⁃28. doi: 10.1111/j.1468⁃3083. 2011.04310.x.
|
| ［13］ |
Falay Gur T, Erdemir AV, Gurel MS, et al. The investigation of the relationships of demodex density with inflammatory response and oxidative stress in rosacea［J］. Arch Dermatol Res, 2018,310（9）:759⁃767. doi: 10.1007/s00403⁃018⁃1857⁃1.
|
| ［14］ |
Altunisik N, Turkmen D, Sener S. Investigation of the relationship between inflammatory blood parameters and rosacea and demodex infestation［J］. J Cosmet Dermatol, 2020,19（8）:2105⁃2108. doi: 10.1111/jocd.13254.
|
| ［15］ |
Lacey N, Russell⁃Hallinan A, Zouboulis CC, et al. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea［J］. Br J Dermatol, 2018,179（2）:420⁃430. doi: 10.1111/bjd.16540.
|
| ［16］ |
Li T, Zeng Q, Chen X, et al. The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway［J］. Mol Med Rep, 2018,17（6）:8385⁃8390. doi: 10. 3892/mmr.2018.8887.
|
| ［17］ |
Gazi U, Gureser AS, Oztekin A, et al. Skin⁃homing T⁃cell responses associated with Demodex infestation and rosacea［J］. Parasite Immunol, 2019,41（8）:e12658. doi: 10.1111/pim.12658.
|
| ［18］ |
Forton F, De Maertelaer V. Erythematotelangiectatic rosacea may be associated with a subclinical stage of demodicosis: a case⁃control study［J］. Br J Dermatol, 2019,181（4）:818⁃825. doi: 10. 1111/bjd.17817.
|
| ［19］ |
Forton F, De Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms［J］. J Eur Acad Dermatol Venereol, 2020,34（2）:365⁃369. doi: 10.1111/jdv.15938.
|
| ［20］ |
McMahon FW, Gallagher C, O′Reilly N, et al. Exposure of a corneal epithelial cell line （hTCEpi） to Demodex⁃associated Bacillus proteins results in an inflammatory response［J］. Invest Ophthalmol Vis Sci, 2014,55（10）:7019⁃7028. doi: 10.1167/iovs. 14⁃15018.
|
| ［21］ |
Maher A, Staunton K, Kavanagh K. Analysis of the effect of temperature on protein abundance in Demodex⁃associated Bacillus oleronius［J］. Pathog Dis, 2018,76（4）. doi: 10.1093/femspd/fty032.
|
| ［22］ |
O′Reilly N, Bergin D, Reeves EP, et al. Demodex⁃associated bacterial proteins induce neutrophil activation［J］. Br J Dermatol, 2012,166（4）:753⁃760. doi: 10.1111/j.1365⁃2133.2011.10746.x.
|
| ［23］ |
McMahon F, Banville N, Bergin DA, et al. Activation of neutrophils via IP3 pathway following exposure to Demodex⁃associated bacterial proteins［J］. Inflammation, 2016,39（1）:425⁃433. doi: 10.1007/s10753⁃015⁃0264⁃4.
|
| ［24］ |
Jahns AC, Lundskog B, Dahlberg I, et al. No link between rosacea and Propionibacterium acnes［J］. APMIS, 2012,120（11）:922⁃925. doi: 10.1111/j.1600⁃0463.2012.02920.x.
|
| ［25］ |
Thompson KG, Rainer BM, Antonescu C, et al. Comparison of the skin microbiota in acne and rosacea［J/OL］. Exp Dermatol, 2020. ［2020⁃04⁃11］. doi: 10.1111/exd.14098. ［published online ahead of print Apr 11,2020］.
|
| ［26］ |
Tauch A, Fernández⁃Natal I, Soriano F. A microbiological and clinical review on Corynebacterium kroppenstedtii［J］. Int J Infect Dis, 2016,48:33⁃39. doi: 10.1016/j.ijid.2016.04.023.
|
| ［27］ |
Clanner⁃Engelshofen BM, French LE, Reinholz M. Corynebacterium kroppenstedtii subsp. demodicis is the endobacterium of Demodex folliculorum［J］. J Eur Acad Dermatol Venereol, 2020,34（5）:1043⁃1049. doi: 10.1111/jdv. 16069.
|
| ［28］ |
Sobolewska B, Doycheva D, Deuter CM, et al. Efficacy of topical ivermectin for the treatment of cutaneous and ocular rosacea［J/OL］. Ocul Immunol Inflamm, 2020. ［2020⁃04⁃07］. doi: 10.1080/09273948.2020.1727531. ［published online ahead of print Apr 7,2020］.
|
| ［29］ |
Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase Ⅲ clinical trials evaluating anti⁃inflammatory dose doxycycline （40⁃mg doxycycline, USP capsules） administered once daily for treatment of rosacea［J］. J Am Acad Dermatol, 2007,56（5）:791⁃802. doi: 10.1016/j.jaad.2006.11.021.
|
| ［30］ |
Gold LS, Del Rosso JQ, Kircik L, et al. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: results of 2 phase 3, randomized, clinical trials［J］. J Am Acad Dermatol, 2020,82（5）:1166⁃1173. doi: 10.1016/j.jaad.2020.01.043.
|
